SPRINGFIELD — To provide greater flexibility for healthcare providers and businesses receiving prescription drug deliveries while maintaining safeguards for controlled substances State Senator Laura Ellman is advancing House Bill 4953, reducing burdens for businesses operating across multiple sites while preserving accountability and safety standards.
“Health care providers and businesses often operate across multiple locations, and outdated delivery rules can create unnecessary administrative hurdles,” said Ellman (D-Naperville). “This measure provides flexibility for non-controlled prescription drugs while keeping important protections in place for controlled substances.”
House Bill 4953 would update Illinois’ Wholesale Drug Distribution Licensing Act to allow prescription drugs that are not controlled substances to be delivered to additional authorized health care locations if the Illinois Department of Financial and Professional Regulation receives notice from the licensee approving the delivery location.
Current law generally requires wholesale drug distributors to deliver pharmaceuticals only to the address listed on a license and to individuals whose authorization to receive the drugs has been verified. Under the bill, non-controlled prescription drugs could also be delivered to a health care entity authorized by the license holder and reported to IDFPR.
The legislation would maintain existing requirements under the Illinois Controlled Substances Act, meaning controlled substances may still only be delivered to registered places of business or professional practice.
“This is a commonsense update that reflects how many healthcare operations function today,” said Ellman. “We can improve efficiency without compromising patient safety or oversight.”
House Bill 4953 passed the Senate Licensed Activities Committee and heads to the full Senate for further consideration .
